Cargando…

Multipass haemodialysis: a novel dialysis modality

INTRODUCTION: Most home haemodialysis (HD) modalities are limited to home use since they are based on a single-pass (SP) technique, which requires preparation of large amounts of dialysate. We present a new dialysis method, which requires minimal dialysate volumes, continuously recycled during treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Heaf, James Goya, Axelsen, Mette, Pedersen, Robert Smith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661003/
https://www.ncbi.nlm.nih.gov/pubmed/23136214
http://dx.doi.org/10.1093/ndt/gfs484
_version_ 1782270619005485056
author Heaf, James Goya
Axelsen, Mette
Pedersen, Robert Smith
author_facet Heaf, James Goya
Axelsen, Mette
Pedersen, Robert Smith
author_sort Heaf, James Goya
collection PubMed
description INTRODUCTION: Most home haemodialysis (HD) modalities are limited to home use since they are based on a single-pass (SP) technique, which requires preparation of large amounts of dialysate. We present a new dialysis method, which requires minimal dialysate volumes, continuously recycled during treatment [multipass HD (MPHD)]. Theoretical calculations suggest that MPHD performed six times weekly for 8 h/night, using a dialysate bath containing 50% of the calculated body water, will achieve urea clearances equivalent to conventional HD 4 h thrice weekly, and a substantial clearance of higher middle molecules. METHODS: Ten stable HD patients were dialyzed for 4 h using standard SPHD (dialysate flow 500 mL/min). Used dialysate was collected. One week later, an 8-h MPHD was performed. The dialysate volume was 50% of the calculated water volume, the dialysate inflow 500 mL/min−0.5 × ultrafiltration/min and the outflow 500 mL/min + 0.5 × ultrafiltration/min. Elimination rates of urea, creatinine, uric acid, phosphate and β2-microglobulin (B2M) and dialysate saturation were determined hourly. RESULTS: Three hours of MPHD removed 49, 54, 50, 51 and 57%, respectively, of the amounts of urea, creatinine, uric acid, phosphate and B2M that were removed by 4 h conventional HD. The corresponding figures after 8 h MPHD were 63, 78, 74, 78 and 111%. CONCLUSIONS: Clearance of small molecules using MPHD 6 × 8 h/week will exceed traditional HD 3 × 4 h/week. Similarly, clearance of large molecules will significantly exceed traditional HD and HD 5 × 2.5 h/week. This modality will increase patients' freedom of movement compared with traditional home HD. The new method can also be used in the intensive care unit and for automated peritoneal dialysis.
format Online
Article
Text
id pubmed-3661003
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-36610032013-05-22 Multipass haemodialysis: a novel dialysis modality Heaf, James Goya Axelsen, Mette Pedersen, Robert Smith Nephrol Dial Transplant Clinical Science INTRODUCTION: Most home haemodialysis (HD) modalities are limited to home use since they are based on a single-pass (SP) technique, which requires preparation of large amounts of dialysate. We present a new dialysis method, which requires minimal dialysate volumes, continuously recycled during treatment [multipass HD (MPHD)]. Theoretical calculations suggest that MPHD performed six times weekly for 8 h/night, using a dialysate bath containing 50% of the calculated body water, will achieve urea clearances equivalent to conventional HD 4 h thrice weekly, and a substantial clearance of higher middle molecules. METHODS: Ten stable HD patients were dialyzed for 4 h using standard SPHD (dialysate flow 500 mL/min). Used dialysate was collected. One week later, an 8-h MPHD was performed. The dialysate volume was 50% of the calculated water volume, the dialysate inflow 500 mL/min−0.5 × ultrafiltration/min and the outflow 500 mL/min + 0.5 × ultrafiltration/min. Elimination rates of urea, creatinine, uric acid, phosphate and β2-microglobulin (B2M) and dialysate saturation were determined hourly. RESULTS: Three hours of MPHD removed 49, 54, 50, 51 and 57%, respectively, of the amounts of urea, creatinine, uric acid, phosphate and B2M that were removed by 4 h conventional HD. The corresponding figures after 8 h MPHD were 63, 78, 74, 78 and 111%. CONCLUSIONS: Clearance of small molecules using MPHD 6 × 8 h/week will exceed traditional HD 3 × 4 h/week. Similarly, clearance of large molecules will significantly exceed traditional HD and HD 5 × 2.5 h/week. This modality will increase patients' freedom of movement compared with traditional home HD. The new method can also be used in the intensive care unit and for automated peritoneal dialysis. Oxford University Press 2013-05 2012-11-07 /pmc/articles/PMC3661003/ /pubmed/23136214 http://dx.doi.org/10.1093/ndt/gfs484 Text en © The Author 2012. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
Heaf, James Goya
Axelsen, Mette
Pedersen, Robert Smith
Multipass haemodialysis: a novel dialysis modality
title Multipass haemodialysis: a novel dialysis modality
title_full Multipass haemodialysis: a novel dialysis modality
title_fullStr Multipass haemodialysis: a novel dialysis modality
title_full_unstemmed Multipass haemodialysis: a novel dialysis modality
title_short Multipass haemodialysis: a novel dialysis modality
title_sort multipass haemodialysis: a novel dialysis modality
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661003/
https://www.ncbi.nlm.nih.gov/pubmed/23136214
http://dx.doi.org/10.1093/ndt/gfs484
work_keys_str_mv AT heafjamesgoya multipasshaemodialysisanoveldialysismodality
AT axelsenmette multipasshaemodialysisanoveldialysismodality
AT pedersenrobertsmith multipasshaemodialysisanoveldialysismodality